logo
Select company
Select metric
$ 26.47MNet Cash Flow - Financing
VS
Market
26
Sector
27
Industry
35
History
53
$ 1.65Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information

Ticker

LCTX

Company Name

LINEAGE CELL THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

LINEAGE CELL THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LCTX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 26.47M
3/31/2025$ 26.88M
12/31/2024$ 35.86M
9/30/2024$ 14.11M
6/30/2024$ 14.92M
3/31/2024$ 20.44M
12/31/2023$ 6.42M
9/30/2023$ 6.56M
6/30/2023$ 6.71M
3/31/2023$ 1.12M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 25.05M.
  • Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average CF - Financing has been $ 21.52M.
  • The median CF - Financing for LINEAGE CELL THERAPEUTICS INC during this period was $ 18.46M
  • LINEAGE CELL THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 61.63M.
  • The lowest CF - Financing recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe $ 1.12M

LINEAGE CELL THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
TVRD : TVARDI THERAPEUTICS INC $ 20.71MCRBU : CARIBOU BIOSCIENCES INC $ 4.58MSRZN : SURROZEN INC $ 71.35MPRTA : PROTHENA CORP PUBLIC LTD CO $ 152KFATE : FATE THERAPEUTICS INC $ 4.46MKRRO : KORRO BIO INC $ 1.84MCAPR : CAPRICOR THERAPEUTICS INC $ 148.48MTNXP : TONIX PHARMACEUTICALS HOLDING CORP $ 188.59MOCGN : OCUGEN INC $ 63.77MCRVO : CERVOMED INC $ -13.34K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

LCTX - Net Cash Flow - Financing, Last 5 years

$ 1.12M

Minimum

Mar 31, 2023

$ 61.63M

Maximum

Jun 30, 2021

$ 21.52M

Average

$ 18.46M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M